Incorrect labeling prompts OTC medicine recall

The mishap means that patients don't have the correct information about side-effects, drug interactions, and active ingredients.

RB, formerly Reckitt Benckiser, has voluntarily recalled bottles of Mucinex, because the over-the-counter medication may not have the correct corresponding drug facts label on the back.

The products are correctly labeled on the front of the bottle and lists all active ingredients, the company said.

According to News for Shoppers, 1.5 million bottles are involved in the recall.

This mislabeling could cause the user to be unaware of side effects and/or risks associated with the ingestion of certain product ingredients which include Acetaminophen, Dextromethorphan, Guaifenesin, Phenylephrine, and/or Diphenhydramine.

The recall includes liquid bottles of Mucinex Fast-Max Night Time Cold &Flu, MucinexFast-Max Cold & Sinus, MucinexFast-Max Severe Congestion & Cough, and MucinexFast-Max Cold, Flu & Sore Throat.

Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026